Cardiopulmonary function assessment kit utilizing fluorescence immunoassay technology for rapid detection and quantification of cardiac and pulmonary biomarkers. Enables clinical laboratories to evaluate cardiopulmonary status through simultaneous measurement of five key analytes, supporting diagnos...
Manufactured by
China
Quidel Corporation (NASDAQ: QDEL) is a US-based medical diagnostics company founded in 1979, with core competencies in immunoassay technology, automated manufacturing, monoclonal antibody development, and molecular diagnostics. Quidel China, established in 2018, markets cardiac biomarker testing systems (Triage MeterPro), BNP assays for Beckman platforms, and Sofia respiratory virus detection instruments with associated reagents for Influenza A/B and RSV.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Hangzhou Pefectech Biotechnology Co., Ltd.
China · 1 relevant product
OptiBio Co., Ltd.
South Korea · 2 relevant products
Wuhan Life Origin Biotech Joint Stock Co., Ltd.
China · 1 relevant product
49 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →7 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 88 closest product alternatives
Hangzhou Pefectech Biotechnology Co., Ltd. · China
Diagnostic test kits utilizing fluorescence immunoassay technology for rapid detection of various health conditions. These tests are companion products to the fluorescence analyzer platform.
OptiBio Co., Ltd. · South Korea
Multi-parameter fluorescence immunoassay diagnostic test kits enabling point-of-care testing for 20+ clinical parameters. These POCT reagents provide rapid, sensitive detection across infectious disease, cardiac, and metabolic markers, supporting timely clinical decision-making in resource-limited and acute care settings.
Wuhan Life Origin Biotech Joint Stock Co., Ltd. · China
Fluorescence immunoassay POCT rapid diagnostic kits for point-of-care testing, enabling quick detection of biomarkers at the bedside or clinical setting. These kits utilize fluorescence technology to deliver sensitive and specific results without requiring centralized laboratory infrastructure, supporting rapid clinical decision-making.
85 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products